GLP-1 Weight Loss Drugs Linked to Rare Brain Condition in New Study
New study links GLP-1 drugs to rare brain condition. Patients with severe side effects face increased risk, experts warn.
POLICY WIRE — City, Country — A new study has uncovered a potential association between GLP-1 weight loss and diabetes medications and a rare neurological condition known as Wernicke encephalopathy.
The research, which analyzed U.S. Food and Drug Administration adverse event reports and medical literature, identified 15 cases of the condition among users of these drugs between 2023 and 2024.
Wernicke encephalopathy is a serious neurological disorder caused by a severe deficiency of vitamin B1, which can lead to permanent memory loss and cognitive impairment. While the condition is rare, experts say it is not to be ignored, especially for patients experiencing significant gastrointestinal side effects.
Dr. Karthik Achari, a Chicago-based clinician not involved in the study, noted that while the number of cases is small, the link is real and warrants attention. This is out of millions of people on these medications, so it’s rare, but it’s serious, he said.
📄 POLICY WIRE WHITEPAPER PUBLISHED: PAKISTAN’S NATIONAL SECURITY POLICY PRIORITIES
The majority of the 15 cases were associated with drugs containing semaglutide, such as Ozempic and Wegovy, or tirzepatide, found in Zepbound. Many patients reported symptoms like vomiting, diarrhea, and loss of appetite, which may contribute to vitamin B1 deficiency.
Researchers emphasized that while the findings suggest a possible connection, the FDA reports do not confirm causation. More studies are needed before any definitive conclusions can be drawn. However, they cautioned against discontinuing prescribed medications based solely on this study.
Earlier research has also linked a small number of GLP-1 drug users to the same brain condition. Dr. Manar Kadhem from Egypt’s Mansoura University noted that some patients experienced severe gastroparesis and persistent vomiting, further highlighting the need for vigilance.
Immediate treatment with thiamine is crucial to prevent long-term damage. The Cleveland Clinic states that prompt intervention can relieve symptoms and reduce the risk of irreversible brain function impairment.
Reporting by Policy-Wire (PW)
